NDC product
POWDER · Catalent Pharma Solutions, LLC
NDC 11014-0175 · Catalent Pharma Solutions, LLC
Key facts
| Product NDC | 11014-0175 |
|---|---|
| Nonproprietary name | Atazanavir |
| Substances | ATAZANAVIR SULFATE |
| Dosage form | POWDER |
| Labeler | Catalent Pharma Solutions, LLC |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Dec 19, 2014 |
| Marketing end | Sep 30, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory